ASCRS

New advancements in IOL technology is exciting for presbyopia treatment

Catching up after ASCRS 2022, Ora's Caitlin Black, senior director and therapeutic area head of medical devices, talks about the next generation of ophthalmic device therapies and diagnostics, clinical trial updates and new innovations that are most exciting for presbyopia treatment.

Dexamethasone plug opens opportunity for treatment that will bring patients relief, help alleviate and mitigate the signs and symptoms associated with conjunctivitis from allergies

A second FDA indication for the treatment of allergic conjunctivitis proves promising for patient relief.

New noninvasive technology shows positive safety and efficacy for the treatment of open angle glaucoma

Two year data shows a promising future for the OCD guided, noninvasive technology for glaucoma treatment.

Cataract classification method allows for higher success rates of cataract surgery

May 05, 2022

Alex Dastgheib, MD, ABO, discusses the findings of the paper, "325 Cases of Phacoemulsification in Blind Cataracts," presented at the 2022 ASCRS conference in Washington, DC. The paper won the Challenging Cases session during the meeting.